scholarly journals Oral health status of adult heart transplant recipients in China

Medicine ◽  
2018 ◽  
Vol 97 (38) ◽  
pp. e12508 ◽  
Author(s):  
Ying Cao ◽  
Xi Chen ◽  
Yixin Jia ◽  
Yalin Lv ◽  
Zheng Sun
Keyword(s):  
Health Status ◽  
Oral Health ◽  
Heart Transplant ◽  
Oral Health Status ◽  
Transplant Recipients ◽  
Adult Heart ◽  
Heart Transplant Recipients

Adherence to immunosuppression in adult heart transplant recipients: A systematic review

2021 ◽  
pp. 100651
Author(s):  
Tasmeen Hussain ◽  
Keira Nassetta ◽  
Linda C. O'Dwyer ◽  
Jane E. Wilcox ◽  
Sherif M. Badawy
Keyword(s):  
Systematic Review ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Adult Heart ◽  
Heart Transplant Recipients

scholarly journals The psychological experiences of adult heart transplant recipients: A systematic review and meta-summary of qualitative findings

Heart & Lung ◽  
2013 ◽  
Vol 42 (6) ◽  
pp. 449-455 ◽  
Author(s):  
Aaron Conway ◽  
Verena Schadewaldt ◽  
Robyn Clark ◽  
Chantal Ski ◽  
David R. Thompson ◽  
...  
Keyword(s):  
Systematic Review ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Adult Heart ◽  
Heart Transplant Recipients ◽  
Psychological Experiences

CLINICAL OUTCOMES OF ADULT HEART TRANSPLANT RECIPIENTS CARED FOR AT A LOW-VOLUME NON-TRANSPLANT CENTER

2014 ◽  
Vol 30 (10) ◽  
pp. S199-S200
Author(s):  
K.H. Wallace ◽  
S.R. Zieroth ◽  
A. Schaffer ◽  
L.A. Schafer ◽  
FJ Cordova Perez
Keyword(s):  
Clinical Outcomes ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Adult Heart ◽  
Transplant Center ◽  
Heart Transplant Recipients ◽  
Low Volume

Heart Transplantation

2014 ◽  
Author(s):  
Michael M. Givertz
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Heart Transplant ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Transplant Recipients ◽  
Allograft Vasculopathy ◽  
Adult Heart ◽  
Heart Transplantations ◽  
Heart Transplant Recipients

Heart failure is a major public health problem with significant associated morbidity and mortality. Heart transplantation remains the standard of care for highly selected patients with end-stage heart failure and absence of contraindications to transplantation. This chapter discusses indications and contraindications for transplantation; recipient evaluation, selection, and management; donor selection; timing of the procedure and surgical technique; medical management, including immunosuppression, prevention and treatment of infections, and other standard or preventive therapy; late complications; and functional status and long-term survival. Tables describe patient referral to a specialized center for heart transplantations; guidelines of indications for cardiac transplantation; organ dysfunction; pretransplantation evaluation; waiting lists; therapeutic options for patients with advanced or refractory heart failure; treating highly sensitized patients; suggested vaccinations; guidelines for donor hearts with severe infection; high-risk donor behavior; hemodynamic effect of commonly used parenteral agents; frequency of follow-up evaluations; revised International Society for Heart and Lung Transplantation (ISHLT) formulation for diagnosis of cardiac allograft rejection and suggested treatment; function of immunosuppressive agents; administration, dosing, monitoring, and adverse effects of commonly used immunosuppressants; common agents that interfere with tacrolimus and cyclosporine; cytomegalovirus prophylaxis and valganciclovir based on estimated renal function; cumulative morbidity rates in adult heart transplant survivors; and therapies to prevent and treat osteoporosis posttransplantation. Figures depict the progression of heart failure; change in functional status over time in patients with chronic heart failure; US heart transplantations in 2012; percentage of US adult wait-listed patients who received a donor heart transplant within a year and donation rates by state; bicaval surgical technique; endomyocardial biopsies; timeline of infection following solid-organ transplantation; cardiac allograft vasculopathy; and squamous cell carcinomas in a heart transplant patient. Graphs show adult worldwide heart transplantation volume from 1982 to 2010; changing characteristics of US adult heart transplant recipients; relative risk of death and development of cardiac allograft vasculopathy; posttransplantation immunosuppression at 1 and 5 years in the ISHLT Registry; older donor age and risk of developing cardiac allograft vasculopathy; freedom from malignancy in the ISHLT Registry; employment status of adult heart transplant recipients; adult heart transplant survival; and patient survival among US heart transplant recipients by gender and race. This review contains 18 highly rendered figures, 20 tables, and 109 references.

Sign in / Sign up

Export Citation Format

Share Document